Evaluating Cetuximab Regimens in Head and Neck Cancer: Insights from a Retrospective Cohort Study
CPF2 exhibits practical advantages and comparable effectiveness, making it the preferred treatment regimen for eligible patients. Further studies with larger populations and molecular stratifications are needed to confirm these findings and develop better treatment strategies.
Authors
- Chuan‐Chien Yang
- Shyh‐An Yeh (ORCID: https://orcid.org/0000-0002-0580-9111)
- Hung-Ju Li
- Yu‐Chieh Su (ORCID: https://orcid.org/0000-0002-1771-9017)
- Chih-Chun Wang
- Ta‐Cheng Huang
- Wen-Hui Chen
Institutions
- E-Da Hospital (TW)
- I-Shou University (TW)
Publication Details
- Journal
- Cancers
- Published
- 2025-01-10
- DOI
- https://doi.org/10.3390/cancers17020210
- Citations
- 3
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 5.54
Funders
- E-Da Hospital